Intracranial astrocytoma: pathology, diagnosis and clinical presentation
- PMID: 1826721
- DOI: 10.1097/01376517-199102000-00002
Intracranial astrocytoma: pathology, diagnosis and clinical presentation
Abstract
Approximately 15,000 deaths a year occur in the United States from brain tumors. Astrocytomas, the most common primary tumor of the central nervous system, develop from astrocytes, the neuroglial support cell. Normal astrocytes can undergo anaplasia for unknown reasons and form brain tumors. Astrocytomas are graded from I to IV. As normal brain tissue is displaced by tumor cells, varying signs and symptoms develop, depending on tumor site and size. The goal of surgery, radiation, chemotherapy or a combination of these treatments is to decrease tumor size and improve quality of life and survival time. This article addresses astrocyte cell development, classification of astrocytomas, theories of tumor development, signs and symptoms of astrocytoma, diagnosis and treatment of the astrocytoma. The role of the nurse is explored and two case histories are presented.
Similar articles
-
Development of anaplastic changes in low-grade astrocytomas of childhood.Neurosurgery. 1994 Jan;34(1):68-78. Neurosurgery. 1994. PMID: 8121571
-
Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate.Am J Ther. 2006 Sep-Oct;13(5):458-9. doi: 10.1097/01.mjt.0000208270.57626.c0. Am J Ther. 2006. PMID: 16988542
-
Astrocytomas: the clinical picture.Clin J Oncol Nurs. 2000 Jul-Aug;4(4):153-8. Clin J Oncol Nurs. 2000. PMID: 11261094 Review.
-
Gemistocytic astrocytomas: a reappraisal.J Neurosurg. 1991 Mar;74(3):399-406. doi: 10.3171/jns.1991.74.3.0399. J Neurosurg. 1991. PMID: 1993905
-
ImuVert therapy in the treatment of recurrent malignant astrocytomas: nursing implications.J Neurosci Nurs. 1991 Feb;23(1):29-33. doi: 10.1097/01376517-199102000-00006. J Neurosci Nurs. 1991. PMID: 1826714 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials